Spots Global Cancer Trial Database for renal
Every month we try and update this database with for renal cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study | NCT02793128 | Carcinoma, Tran... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto | NCT05874921 | Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Canc... Urothelial Carc... Carcinoma, Tran... Transitional Ce... | Jelmyto (mitomy... | 18 Years - | UroGen Pharma Ltd. | |
| Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma | NCT01606345 | Urothelial Carc... | Valrubicin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) | NCT00100685 | Renal Cell Carc... Metastases | Volociximab (an... | 18 Years - | Abbott | |
| Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) | NCT00100685 | Renal Cell Carc... Metastases | Volociximab (an... | 18 Years - | Abbott | |
| A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
| TroVax Renal Immunotherapy Survival Trial | NCT00397345 | Clear Cell Rena... | Trovax Placebo Standard of car... | 18 Years - | Oxford BioMedica | |
| Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma | NCT00176280 | Renal Cell Carc... | Leukine Dexamethasone | 18 Years - | University of Kentucky | |
| A Study of Axitinib in Advanced Carcinoid Tumors | NCT01435122 | Carcinoid Tumor | Axitinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer | NCT01784978 | Metastatic Rena... | Sunitinib Everolimus | 18 Years - | Associació per a la Recerca Oncologica, Spain | |
| Study of CP-461 in Patients With Advanced Renal Cell Cancer | NCT00036036 | Renal Cell Carc... | CP-461 | 18 Years - | Astellas Pharma Inc | |
| Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma | NCT00729053 | Renal Cell Carc... | IMO-2055 | 18 Years - | Idera Pharmaceuticals, Inc. | |
| A Study of Axitinib in Advanced Carcinoid Tumors | NCT01435122 | Carcinoid Tumor | Axitinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Development of Diagnostics and Treatment of Urological Cancers | NCT02994758 | Prostate Carcin... Kidney Cancer Urothelial Carc... Testicular Canc... Penile Cancer | Personalised tr... | 18 Years - | Helsinki University Central Hospital | |
| Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma | NCT00318110 | Metastatic Rena... | NST using MUD f... | 18 Years - 65 Years | Center for International Blood and Marrow Transplant Research | |
| Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer | NCT02300610 | Bladder Cancer Carcinoma, Tran... Renal Pelvis Ca... Ureter Cancer Urethra Cancer | Enzalutamide Cisplatin Gemcitabine | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) | NCT01216371 | Renal Cell Carc... Pulmonary Metas... | Sunitinib Placebo | 18 Years - 75 Years | Association of Urologic Oncology (AUO) | |
| A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma | NCT00422344 | Renal Cell Carc... Kidney Cancer | RAD001, Sunitin... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase I Study of OSI-930 and Erlotinib in Cancer Tumors | NCT00603356 | Advanced Solid ... | OSI-930 and erl... | 18 Years - | Astellas Pharma Inc | |
| Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma | NCT01598038 | Renal Cell Carc... | Blood sample | 18 Years - | Centre Francois Baclesse | |
| Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors | NCT00972205 | Cervical Ovarian Lung Breast Renal | paclitaxel CBT-1(Registere... Tc 99m sestamib... | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Study of CP-461 in Patients With Advanced Renal Cell Cancer | NCT00036036 | Renal Cell Carc... | CP-461 | 18 Years - | Astellas Pharma Inc | |
| A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
| Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism | NCT03174847 | Primary Aldoste... Primary Aldoste... Primary Aldoste... | Adrenalectomy Mineralocortico... | 21 Years - 80 Years | Changi General Hospital | |
| Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism | NCT01439867 | Chronic Kidney ... Hyperparathyroi... | Cinacalcet hydr... Standard of Car... | 28 Days - 2189 Days | Amgen | |
| Identification of Novel Biomarkers of Response to Systemic Treatments in Renal Cell Cancer | NCT04060537 | Carcinoma, Rena... | Laboratory anal... Application of ... | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma | NCT01598038 | Renal Cell Carc... | Blood sample | 18 Years - | Centre Francois Baclesse | |
| A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors | NCT02743637 | Advanced Malign... Advanced Solid ... Neoplasm Metastasis | SDX-7320 | 21 Years - 85 Years | SynDevRx, Inc. | |
| Vandetanib to Treat Advanced Kidney Cancer | NCT01372813 | Advanced Clear ... | vandetanib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism | NCT01439867 | Chronic Kidney ... Hyperparathyroi... | Cinacalcet hydr... Standard of Car... | 28 Days - 2189 Days | Amgen | |
| Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism | NCT03174847 | Primary Aldoste... Primary Aldoste... Primary Aldoste... | Adrenalectomy Mineralocortico... | 21 Years - 80 Years | Changi General Hospital | |
| A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment | NCT02301117 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
| The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study | NCT02793128 | Carcinoma, Tran... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer | NCT00529802 | Carcinoma, Rena... | RAD001 | 18 Years - | University of Chicago | |
| A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases | NCT01676428 | Cancer | Radiotherapy | 18 Years - | Peter MacCallum Cancer Centre, Australia | |
| Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma | NCT04698213 | Renal Carcinoma... | Axitinib Oral T... Avelumab | 18 Years - | Consorzio Oncotech | |
| Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer | NCT00126178 | Kidney Cancer Renal Cell Carc... | HSPPC-96 | 18 Years - | Agenus Inc. | |
| Efficacy and Safety of UGN-101 in Recurrent Patients | NCT04006691 | Carcinoma Transitional Ce... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer | NCT02300610 | Bladder Cancer Carcinoma, Tran... Renal Pelvis Ca... Ureter Cancer Urethra Cancer | Enzalutamide Cisplatin Gemcitabine | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma | NCT01764607 | Squamous Cell S... | Sirolimus | 18 Years - | University of Florida | |
| Development of Diagnostics and Treatment of Urological Cancers | NCT02994758 | Prostate Carcin... Kidney Cancer Urothelial Carc... Testicular Canc... Penile Cancer | Personalised tr... | 18 Years - | Helsinki University Central Hospital | |
| Pediatric Chronic Kidney Disease Safety and Efficacy | NCT01277510 | Chronic Kidney ... Hyperparathyroi... Hyperparathyroi... Kidney Disease Secondary Hyper... | cinacalcet caps... placebo Standard of Car... | 6 Years - 17 Years | Amgen | |
| ATN-161 in Advanced Renal Cell Cancer | NCT00131651 | Carcinoma, Rena... | ATN-161 | 18 Years - | Attenuon | |
| Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma | NCT00082459 | Renal Cell Carc... | autologous huma... | 18 Years - | Agenus Inc. | |
| A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma | NCT00422344 | Renal Cell Carc... Kidney Cancer | RAD001, Sunitin... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors | NCT02743637 | Advanced Malign... Advanced Solid ... Neoplasm Metastasis | SDX-7320 | 21 Years - 85 Years | SynDevRx, Inc. | |
| Vandetanib to Treat Advanced Kidney Cancer | NCT01372813 | Advanced Clear ... | vandetanib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma | NCT00176280 | Renal Cell Carc... | Leukine Dexamethasone | 18 Years - | University of Kentucky |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
